Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | ARG1 | P05089 | 1/20 | 0.31 |
| ▸ | ARG2 | P78540 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | KDM5A | P29375 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycerin SCHEMBL5691791 | 0.94 | LMNA (0.39) | USP2LMNAALDH1A1KDM4EMAPK1 | |
| Boric Acid SCHEMBL28138844 | 0.88 | ALDH1A1 (0.41) | LMNAALDH1A1MAPK1MEN1KMT2A | |
| Trolamine SCHEMBL28109599 | 0.85 | LMNA (0.47) | LMNAALDH1A1KDM4ETSHR | |
| SCHEMBL25684971 | 0.82 | KDM4E (0.44) | USP2LMNAALDH1A1KDM4EMAPK1 | |
| Boric Acid SCHEMBL28247103 | 0.81 | SMN1; SMN2 (0.43) | LMNAALDH1A1MEN1KMT2ACA12 | |
| SCHEMBL43801 | 0.81 | ALDH1A1 (0.47) | LMNAALDH1A1MAPK1MEN1KMT2A | |
| SCHEMBL20629 | 0.81 | ALDH1A1 (0.47) | LMNAALDH1A1MAPK1MEN1KMT2A | |
| Trolamine SCHEMBL11973736 | 0.81 | ALDH1A1 (0.47) | LMNAALDH1A1MAPK1MEN1KMT2A | |
| Trolamine SCHEMBL28074572 | 0.80 | THRB (0.42) | USP2LMNAALDH1A1KDM4EMEN1 | |
| Boric Acid SCHEMBL32679696 | 0.79 | LMNA (0.46) | LMNAALDH1A1MEN1KMT2ACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1310532-B1 | Phase change inks containing borate esters | XEROX CORP (US) | 2006-05-17 | — | — | EP | claimed |
| US-6682591-B2 | HYDROLYTICALLY STABLE | XEROX CORPORATION | 2004-01-27 | — | — | US | claimed |
| US-20030127020-A1 | Aqueous ink compositions containing borate esters | XEROX CORPORATION | 2003-07-10 | — | — | US | claimed |
| US-6585816-B1 | As vehicle for thermal ink jet printing; nonevaporating, nonspilling | XEROX CORPORATION | 2003-07-01 | — | — | US | claimed |
| EP-1310532-A1 | Phase change inks containing borate esters | Xerox Corporation (US) | 2003-05-14 | — | — | EP | claimed |
| US-9028768-B2 | Metal alkoxides, apparatus for manufacturing metal alkoxides, related methods and uses thereof | AUTERRA, INC. (US) | 2015-05-12 | — | — | US | disclosed |
| US-8877131-B2 | Metal alkoxides, apparatus for manufacturing metal alkoxides, related methods and uses thereof | AUTERRA, INC. (US) | 2014-11-04 | — | — | US | disclosed |
| US-8262867-B2 | Metal alkoxides, apparatus for manufacturing metal alkoxides, related methods and uses thereof | AUTERRA, INC. (US) | 2012-09-11 | — | — | US | disclosed |
| EP-2217387-A1 | METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF | Auterra, Inc. (US) | 2010-08-18 | — | — | EP | disclosed |
| US-20100178218-A1 | METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF | AUTERRA, INC. (US) | 2010-07-15 | — | — | US | disclosed |
| US-20100179339-A1 | METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF | AUTERRA, INC. (US) | 2010-07-15 | — | — | US | disclosed |
| US-20100178220-A1 | METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF | AUTERRA, INC. (US) | 2010-07-15 | — | — | US | disclosed |
| WO-2009070420-A1 | METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF | APPLIED NANOWORKS, INC. (US) | 2009-06-04 | — | — | WO | disclosed |
| US-20090134369-A1 | METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF | APPLIED NANOWORKS, INC. (US) | 2009-05-28 | — | — | US | disclosed |
| EP-1310532-B1 | Phase change inks containing borate esters | XEROX CORP (US) | 2006-05-17 | — | — | EP | disclosed |
| US-6682591-B2 | HYDROLYTICALLY STABLE | XEROX CORPORATION | 2004-01-27 | — | — | US | disclosed |
| US-20030127020-A1 | Aqueous ink compositions containing borate esters | XEROX CORPORATION | 2003-07-10 | — | — | US | disclosed |
| US-6585816-B1 | As vehicle for thermal ink jet printing; nonevaporating, nonspilling | XEROX CORPORATION | 2003-07-01 | — | — | US | disclosed |
| EP-1310532-A1 | Phase change inks containing borate esters | Xerox Corporation (US) | 2003-05-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100179339-A1 | METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF | ADH1A, AKR7A2, PAOX | USP2 2341/4885LMNA 3710/4885ALDH1A1 32/4885 |
| US-20090134369-A1 | METAL ALKOXIDES, APPARATUS FOR MANUFACTURING METAL ALKOXIDES, RELATED METHODS AND USES THEREOF | ADH1A, AKR7A2, PAOX | USP2 2341/4885LMNA 3710/4885ALDH1A1 32/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.